[HTML][HTML] Delivery of biologics: Topical administration

RJ Kulchar, R Singh, S Ding, E Alexander, KW Leong… - Biomaterials, 2023 - Elsevier
Biologics are unaffordable to a large majority of the global population because of
prohibitively expensive fermentation systems, purification and the requirement for cold chain …

Repositioning of anti-diabetic drugs against dementia: insight from molecular perspectives to clinical trials

KEK Mantik, S Kim, B Gu, S Moon, HB Kwak… - International journal of …, 2023 - mdpi.com
Insulin resistance as a hallmark of type 2 DM (T2DM) plays a role in dementia by promoting
pathological lesions or enhancing the vulnerability of the brain. Numerous studies related to …

Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis

C Long, X Han, Y Yang, T Li, Q Zhou… - Frontiers in Aging …, 2022 - frontiersin.org
Background Insulin regulates many aspects of brain function related to mild cognitive
impairment (MCI) or dementia, which can be delivered to the brain center via intranasal (IN) …

Hot spots for the use of intranasal insulin: cerebral ischemia, brain injury, diabetes mellitus, endocrine disorders and postoperative delirium

AO Shpakov, II Zorina, KV Derkach - International Journal of Molecular …, 2023 - mdpi.com
A decrease in the activity of the insulin signaling system of the brain, due to both central
insulin resistance and insulin deficiency, leads to neurodegeneration and impaired …

Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery

T Jamshidnejad-Tosaramandani, S Kashanian, I Karimi… - Polymers, 2024 - mdpi.com
Efficient drug delivery remains a critical challenge for treating neurodegenerative diseases,
such as Alzheimer's disease (AD). Using innovative nanomaterials, delivering current …

Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway

X Kang, D Wang, L Zhang, T Huang, S Liu, X Feng… - Molecular …, 2023 - Springer
Abstract Background Type 2 diabetes (T2D) is an independent risk factor for Alzheimer's
disease (AD). Exendin-4 (Ex-4), a widely used glucagon-like peptide-1 receptor agonist …

Developments in neuroprotection for HIV-associated neurocognitive disorders (HAND)

DL Kolson - Current HIV/AIDS Reports, 2022 - Springer
Abstract Purpose of Review Reducing the risk of HIV-associated neurocognitive disorders
(HAND) is an elusive treatment goal for people living with HIV. Combination antiretroviral …

Delivery of Topical Drugs to the Olfactory Cleft

A Espehana, L Lee, EM Garden, G Klyvyte… - Journal of Clinical …, 2023 - mdpi.com
Olfactory dysfunction affects approximately 20% of the population globally, with incidence
increasing over the age of 60. The pathophysiology is complex, not yet fully understood, and …

Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?

SM de la Monte - Journal of Alzheimer's Disease, 2024 - journals.sagepub.com
Functional impairments in the brain's insulin and insulin-like growth factor (IGF) signal
transduction networks are recognized mediators of dysregulated energy metabolism, a …

Effect of Repeated intranasal administration of different doses of insulin on postoperative delirium, serum τ and Aβ protein in elderly patients undergoing radical …

Q Huang, Q Shi, X Yi, J Zeng, X Dai, L Lin… - Neuropsychiatric …, 2023 - Taylor & Francis
Objective Postoperative delirium is common after general anesthesia in older patients.
However, there are currently no effective preventive measures. This study investigated the …